LISTEN: Scientists Argue that this Genetic Test’s Results are “no better than a coin flip.” The FDA approved it anyway.
Episode Description: Recently, the FDA approved a genetic test for opioid use disorder despite clear opposition from scientists and the FDA advisory panel that had reviewed the evidence. The case demonstrates the space where Pharma’s incentive may drive innovation that may not help–or worse, cause harm. Abdul reflects
